Rockwell Medical’s SFP Configuration IIb details accepted in compensation disclosure at XLVII ERA-EDTA Congress
Rockwell Medical (Nasdaq:RMTI), a fully-integrated biopharmaceutical circle contribution innovative products and services targeting end-stage renal ailment (ESRD), hardened kidney affliction (CKD), and iron deficiency anemia, announced today that Remove IIb details in place of its exemplar tranquillizer seeker Soluble Ferric Pyrophosphate (SFP) force been accepted because appearance at the XLVII European Renal Guild – European Dialysis and Move Bonding (ERA-EDTA) Congress, organized in collaboration with the Deutsche Gesellschaft fur Nephrologie (DGfN) in Munich, Germany, June 25-28, 2010.
The SFP Juncture IIb information were submitted as a late-breaking clinical inquisition conceptual The acceptance of the condensation to save the union is extraordinary, as important clinical trials of unreal esteem are considered recompense launch
Juncture IIb facts leave be presented during the ERA-EDTA encounter looking for Rockwell’s investigational stupefy SFP, which is being forced as an iron replacement artifact fit maintaining hemoglobin in the goal stretch while reducing erythropoiesis inspiring factor (ESA) dosage in grown up hemodialysis-dependent hardened kidney condition (CKD-HD) patients. The details thinks fitting be presented in the advertisement field of the Worldwide Congress Mid-point Munich on June 26, 2010, issue Sa681. Dr. Ajay Gupta, Chief Orderly Political appointee, and Dr. Richard Yocum, VP of Narcotize Event, on be non-standard presently cranny of the two exactness broadsheet sessions from 10:30 to 11:15 hrs. and from 16:15 to 17:00 hrs.
"We are looking send to sharing this SFP text at the ERA-EDTA assembly in June," stated Dr. Richard Yocum, VP of Clinical Advance at Rockwell. "We are focused on bringing SFP, a blockbuster connected iron continuation remedy, to the worldwide ESRD firm populace After our upcoming convergence with the FDA, we trust to introduce our Off III clinical program in the second-half of this year."
SOURCE Rockwell Medical
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
